Evogene Ltd. (EVGN) stock
EVGNNasdaqAgricultural ChemicalsFiscal year ends December 31
$0.35+0.01 (+2.91%)
Close on Nov 18, 2026Market cap $3.05MP/E 0.3Yield –
Evogene gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
For fiscal 2025 it was -$241.00K, down 107.5% from the year before. The highest annual figure on record is $3.20M in fiscal 2024.
Annual gross profit
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$241.00K | -107.5% |
| FY2024 | Dec 31, 2024 | $3.20M | +114.3% |
| FY2023 | Dec 31, 2023 | $1.49M | +94.8% |
| FY2022 | Dec 31, 2022 | $766.00K | +369.9% |
| FY2021 | Dec 31, 2021 | $163.00K | -65.0% |
| FY2020 | Dec 31, 2020 | $466.00K | +11.2% |
| FY2019 | Dec 31, 2019 | $419.00K | +42.0% |
| FY2018 | Dec 31, 2018 | $295.00K | -45.0% |
| FY2017 | Dec 31, 2017 | $536.00K | -40.5% |
| FY2016 | Dec 31, 2016 | $901.00K | -68.6% |
| FY2015 | Dec 31, 2015 | $2.87M | – |
See a number that looks wrong?